These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8730507)

  • 21. Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: a prospective, controlled pilot study.
    Gragnani L; Fabbrizzi A; Triboli E; Urraro T; Boldrini B; Fognani E; Piluso A; Caini P; Ranieri J; Monti M; Laffi G; Zignego AL
    Dig Liver Dis; 2014 Sep; 46(9):833-7. PubMed ID: 24953206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis.
    Saadoun D; Resche Rigon M; Pol S; Thibault V; Blanc F; Pialoux G; Karras A; Bazin-Kara D; Cazorla C; Vittecoq D; Musset L; Peltier J; Decaux O; Ziza JM; Lambotte O; Cacoub P
    J Hepatol; 2015 Jan; 62(1):24-30. PubMed ID: 25135864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rituximab in cryoglobulinemic peripheral neuropathy.
    Cavallo R; Roccatello D; Menegatti E; Naretto C; Napoli F; Baldovino S
    J Neurol; 2009 Jul; 256(7):1076-82. PubMed ID: 19263187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How HCV has changed the approach to mixed cryoglobulinemia.
    Della Rossa A; Baldini C; Tavoni A; Bombardieri S
    Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S115-23. PubMed ID: 19646357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of cryoglobulinemia on the antiviral therapy in patients with chronic hepatitis C].
    Fan XH; Wang LF; Liu LC; Yao Y; Shan Y; Lu HY; Wu CH; Xu XY; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):721-5. PubMed ID: 22409840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C virus but not GB virus C/hepatitis G virus has a role in type II cryoglobulinemia.
    Liu F; Knight GB; Agnello V
    Arthritis Rheum; 1999 Sep; 42(9):1898-901. PubMed ID: 10513805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Viral RNA in nerve tissues of patients with hepatitis C infection and peripheral neuropathy.
    De Martino L; Sampaolo S; Tucci C; Ambrosone L; Budillon A; Migliaresi S; Di Iorio G
    Muscle Nerve; 2003 Jan; 27(1):102-4. PubMed ID: 12508302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis G and hepatitis C RNA viruses coexisting in cryoglobulinemia.
    Tepper JL; Feinman SV; D'Costa L; Sooknannan R; Pruzanski W
    J Rheumatol; 1998 May; 25(5):925-8. PubMed ID: 9598893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Should rituximab be the rescue therapy for refractory mixed cryoglobulinemia associated with hepatitis C?
    Ahmed MS; Wong CF
    J Nephrol; 2007; 20(3):350-6. PubMed ID: 17557269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longterm course of mixed cryoglobulinemia in patients infected with hepatitis C virus.
    Sene D; Ghillani-Dalbin P; Thibault V; Guis L; Musset L; Duhaut P; Poynard T; Piette JC; Cacoub P
    J Rheumatol; 2004 Nov; 31(11):2199-206. PubMed ID: 15517633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of clinical and virologic responses to antiviral treatment and regulatory T cell evolution in patients with hepatitis C virus-induced mixed cryoglobulinemia vasculitis.
    Landau DA; Rosenzwajg M; Saadoun D; Trébeden-Negre H; Klatzmann D; Cacoub P
    Arthritis Rheum; 2008 Sep; 58(9):2897-907. PubMed ID: 18759287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HCV-RNA detection using different PCR methods in sera, cryoglobulins and peripheral blood mononuclear cells of patients with mixed cryoglobulinemia.
    de Maddalena C; Zehender G; Bianchi Bosisio A; Monti G; Monteverde A; Invernizzi F; Galli M
    Clin Exp Rheumatol; 1995; 13 Suppl 13():S119-22. PubMed ID: 8730491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute wrist and foot drop associated with hepatitis C virus related mixed cryoglobulinemia: rapid response to treatment with rituximab.
    Uppal R; Charles E; Lake-Bakaar G
    J Clin Virol; 2010 Jan; 47(1):69-71. PubMed ID: 19892591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term effects of alpha-interferon therapy for type II mixed cryoglobulinemia.
    Mazzaro C; Pozzato G; Moretti M; Crovatto M; Modolo ML; Mazzi G; Santini G
    Haematologica; 1994; 79(4):342-9. PubMed ID: 7528704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral neuropathy without cryoglobulinemia in patients with hepatitis C virus infection.
    Paoletti V; Donnarumma L; De Matteis A; Mammarella A; Labbadia G; Musca A; Francia A
    Panminerva Med; 2000 Sep; 42(3):175-8. PubMed ID: 11218620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus.
    Misiani R; Bellavita P; Fenili D; Vicari O; Marchesi D; Sironi PL; Zilio P; Vernocchi A; Massazza M; Vendramin G
    N Engl J Med; 1994 Mar; 330(11):751-6. PubMed ID: 8107741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature.
    Ferri C; Cacoub P; Mazzaro C; Roccatello D; Scaini P; Sebastiani M; Tavoni A; Zignego AL; De Vita S
    Autoimmun Rev; 2011 Nov; 11(1):48-55. PubMed ID: 21821153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of hepatitis C virus genotypes and viral load in patients with "essential" mixed cryoglobulinemia.
    Sinico RA; Ribero ML; Fornasieri A; Renoldi P; Zhou J; Fasola M; Portera G; Beltrame A; Tagger A; Gibelli A
    Clin Exp Rheumatol; 1995; 13 Suppl 13():S83-5. PubMed ID: 8730483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful and Safe Long-Term Standard Antiviral Therapy in a Patient with "Explosive" Immune Response in Course of HCV-Related Liver Cirrhosis.
    Conca P; Cafaro G; De Renzo A; Coppola A; Cimino E; Tarantino G
    Int J Mol Sci; 2015 Jun; 16(6):14075-85. PubMed ID: 26101866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longterm efficacy of interferon-alpha for extrahepatic disease associated with hepatitis C virus infection.
    Naarendorp M; Kallemuchikkal U; Nuovo GJ; Gorevic PD
    J Rheumatol; 2001 Nov; 28(11):2466-73. PubMed ID: 11708420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.